Endocrinology Flashcards
Describe pathophysiology of T2DM?
In T2DM, the response to insulin is diminished, and this is defined as insulin resistance. During this state, insulin is ineffective and is initially countered by an increase in insulin production to maintain glucose homeostasis, but over time, insulin production decreases, resulting in T2DM.
What criteria is used to diagnose T2DM?
HbA1c > 48mmol
Fasting glucose > 7mmol
Random glucose > 11.1mmol
Usually these are monitored over several repeat readings, to ensure the diagnosis is correct.
In which patient groups is HbA1c not reliable to use?
Under 18 years
Pregnancy or 2 months post-partum
Recent pancreatic injury or surgery
On certain medications causing hyperglycaemia (i.e. steroids)
ESRD
T2DM patients who have had acute illness
What lifestyle advice should be given for T2DM?
Diet - high fibre, low-glycaemic-index sources of carbohydrate (such as fruit, vegetables, wholegrains, and pulses), low-fat dairy products, and oily fish. Low sugar intake, regular meal times.
Weight loss - if obese, aim for 5-10% body weight loss.
Regular exercise
Alcohol advice - risk of hypoglycaemia due to interaction with medications
Smoking cessation
Risk of periodontitis - regular review
How often should HbA1c be measured in T2DM?
3–6 monthly intervals initially until stable on unchanging antidiabetic treatment, and then every 6 months to ensure adequate blood glucose control.
What is the first line medication for T2DM?
Metformin monotherapy
OR
Metformin with SGLT-2 inhibitor if high risk for CVD
When starting an adult with type 2 diabetes on dual therapy with metformin and an SGLT-2 inhibitor as first-line therapy, introduce the drugs sequentially, starting with metformin and checking tolerability. Start the SGLT-2 inhibitor as soon as metformin tolerability is confirmed.
ALSO
ensure you calculate Qrisk - if risk > 10% over 10 years, start statin
What is the MOA of metformin?
Inhibiting hepatic gluconeogenesis and opposing the action of glucagon (released from the alpha cells of islets of langerhans in pancreas in response to hypoglycaemia, in order to stimulate glucose production) - overall lowering the levels of glucose in the bloodstream.
What are some contraindications to metformin?
Renal dysfunction (eGFR < 30mmol)
Congestive cardiac failure needing drug treatment.
Hypersensitivity to metformin.
Acute or chronic metabolic acidosis.
Impaired hepatic function.
What are some side effects of metformin?
Abdominal pain; appetite decreased; diarrhoea; gastrointestinal disorder; nausea; taste altered; vitamin B12 deficiency; vomiting - the GI effects are common, and usually improve with length of treatment
When would you consider first line metformin PLUS SGLT-2 inhibitor for T2DM?
If the patient already has chronic heart failure,
established atherosclerotic cardiovascular disease, or
at high risk of developing cardiovascular disease.
How does an SGLT-2 inhibitor work?
Blocking SGLT2 protein located in the proximal convoluted tubule of the nephron.
The SGLT2 protein is responsible for the resorption of approximately 90% of filtered glucose while the remainder is reabsorbed by SGLT1 proteins found on the distal part of the proximal convoluted tubule.
SGLT2 inhibition results in glycosuria (and natriuresis as the protein is a co-transporter), thereby lowering plasma glucose concentrations.
How does pioglitazone work for T2DM?
Thiazolidinediones, such as pioglitazone, activate peroxisome proliferator-activated receptor gamma (PPAR gamma) to improve insulin sensitivity. However, they also cause increased sodium and fluid retention, thereby leading to a 42% increased risk of incident heart failure.
What is the second line management of T2DM (also what should be offered if metformin is not tolerated or contraindicated)?
Offer an SGLT-2 inhibitor to people with chronic heart failure or established atherosclerotic cardiovascular disease, and consider offering an SGLT-2 inhibitor to people at high risk of developing cardiovascular disease.
For other people, consider one of the following as first-line treatment:
A dipeptidyl peptidase-4 inhibitor (DPP-4 inhibitor).
Pioglitazone.
A sulfonylurea.
A sodium-glucose cotransporter-2 inhibitor (SGLT-2 inhibitor) — this may be considered instead of a DPP-4 inhibitor if a sulfonylurea or pioglitazone is not appropriate.
How does a DPP-4 inhibitor work?
DDP-4 inhibitors work by blocking the action of the enzyme DPP-4, which destroys incretins – hormones - that the body makes. Incretins are naturally produced by the stomach when we eat. They help the body produce more insulin when it’s needed and lowers blood sugar levels
What are some examples of SGLT-2 inhibitors?
Dapagliflozin
Canagliflozin
Empagliflozin
What are some examples of DPP-4 inhibitors?
Sitagliptin
Vildagliptin
What are contraindications to SGLT-2 inhibitors?
CKD - eGFR < 60
liver disease
increasing age - avoid in over 85 years (risk of volume depletion)
active foot disease
What are contrainidications to DDP-4 inhibitors?
Ketoacidosis.
Hepatic impairment — avoid vildagliptin; avoid saxagliptin and alogliptin if severe hepatic impairment.
Heart failure — avoid vildagliptin if severe heart failure; avoid alogliptin if moderate-to-severe heart failure.
what are the different treatment steps for T2DM?
first line - metformin / metformin + SGLT-2 inhibitor if indicated
second line - dual agent therapy - usually metformin + one of the other medications
third line - triple agent therapy
fourth line - insulin
what are some complications of T2DM?
Macrovascular -
Atherosclerotic cardiovascular disease (CVD)
Microvascular -
chronic kidney disease
diabetic retinopathy
peripheral neuropathy
foot complications
what is the role of urine albumin:creatinine ratio?
Performed first thing in the morning
Indicative of level of kidney disease in the context of HTN or T2DM - if urine albumin: creatinine ratio high, this indicates worsening renal disease
what screening is associated with T2DM management?
Diabetic eye screening will be offered at diagnosis and:
Every 2 years for people at low risk of sight loss (no identified diabetic retinopathy on two successive screening tests).
At least annually for all other people with diabetes.
Yearly diabetic foot review
Yearly diabetes review
Yearly screening for diabetic nephropathy - U+E monitoring, urine albumin:creatinine ratio
what are some side effects of SGLT-1 inhibitors?
Urinary and genital infections
Fournier’s gangrene
Normoglycaemic ketoacidosis
Increased risk of lower limb amputation so need to monitor feet carefully
what type of drug is gliclazide?
SULFONYLUREA
examples of sulfonylureas?
Gliclazide
Tolbutamide